Trending Articles

  1. Lupin completes acquisition of VISUfarma from GHO to expand ophthalmology portfolio The addition enhances Lupin's presence in Europe and includes a portfolio of more than 60 innovative eye health products, backed by a well-established commercial infrastructure
  2. University of Exeter leads £4.5m Wellcome-funded initiative to develop bioimaging tools for fungal pathogens An international collaboration spanning the universities of Exeter, Edinburgh and Cape Town has secured £4.5m to develop specialist bioimaging tools for WHO-priority fungal...
  3. Applied Biopharm Consulting awarded Innovation funding to validate AI-powered AAV vector engineering platform Irish biotech consultancy Applied Biopharm Consulting has secured an Innovation Voucher from the Local Enterprise Office Cork North & West to collaborate with an academic...
  4. BASF announces up to 20% price increase on pharmaceutical excipients and selected APIs BASF Pharma Solutions has implemented an immediate global price adjustment of up to 20% across its pharmaceutical excipients and selected active pharmaceutical ingredients...
  5. Lupin signs agreement with LG Life Sciences to launch Insulin Glargine Will sell insulin analogue brand Basugine in India

Upcoming event

Making Pharmaceuticals

21–22 April 2026 | Exhibition | Coventry, UK See all

You may also like

Manufacturing US contract manufacturing deals for FDA-approved drugs hit a five-year low in 2025, as biopharma companies (including major US-headquartered firms) increasingly direct...

Biopharma firms favour European contract manufacturing over US sites despite tariff pressure

Read more
Research & Development Irish biotech consultancy Applied Biopharm Consulting has secured an Innovation Voucher from the Local Enterprise Office Cork North & West to collaborate with an academic...

Applied Biopharm Consulting awarded Innovation funding to validate AI-powered AAV vector engineering platform

Read more
Finance The addition enhances Lupin's presence in Europe and includes a portfolio of more than 60 innovative eye health products, backed by a well-established commercial infrastructure

Lupin completes acquisition of VISUfarma from GHO to expand ophthalmology portfolio

Read more
Manufacturing BASF Pharma Solutions has implemented an immediate global price adjustment of up to 20% across its pharmaceutical excipients and selected active pharmaceutical ingredients...

BASF announces up to 20% price increase on pharmaceutical excipients and selected APIs

Read more
Research & Development An international collaboration spanning the universities of Exeter, Edinburgh and Cape Town has secured £4.5m to develop specialist bioimaging tools for WHO-priority fungal...

University of Exeter leads £4.5m Wellcome-funded initiative to develop bioimaging tools for fungal pathogens

Read more
Finance The purchase is the third multibillion-dollar acquisition for the pharma giant in the past year, as it moves to bolster its cancer portfolio ahead of its best-selling drug...

Merck to acquire cancer biotech Terns Pharmaceuticals for $6.7bn

Read more
Finance Strategic UK investment in next-generation cancer diagnostics and cardiovascular research training is accelerating innovation, reducing barriers to adoption and building the...

Investing in the future of healthcare: from diagnostics innovation to scientific talent pipelines

Read more
Research & Development Just – Evotec Biologics has been selected by BARDA to develop scalable, high-yield manufacturing processes for a monoclonal antibody cocktail targeting filovirus diseases...

Just – Evotec Biologics wins BARDA contract to optimise antibody biomanufacturing against Ebola and Sudan virus

Read more
Finance CVC will retain majority control of the Stuttgart-based equipment specialist as the partnership targets North American expansion and a 72,000-strong installed base service...

Apollo takes 37% stake in Syntegon as CVC eyes next phase of pharmaceutical packaging growth

Read more
Finance New patent protection for Radspherin and a global exclusivity deal for Aspyre Lung underline how strong IP strategies are driving competitive advantage in cancer therapeutics...

Oncoinvent patent win and CellCarta deal highlight IP power in oncology innovation

Read more
Manufacturing The investment marks the second phase of the the company's expansion, funding facility upgrades to increase capacity for suppository, semi-solid and oral solid dose and...

LGM Pharma announces $9 million investment into Colorado and Texas manufacturing facilities

Read more
Finance Global biotechnology innovator TCI Biotech announces an investment of approximately $26.225m to expand its existing US manufacturing facility in American Fork, Utah

TCI Biotech expands US manufacturing with $26m facility investment

Read more
Finance Irish biotech consultancy Applied Biopharm Consulting has received an IP Start Grant from Enterprise Ireland to develop a formal patent strategy around its AI-powered...

Applied Biopharm Consulting secures IP grant to protect AI-driven viral capsid engineering innovations

Read more
Regulatory Despite FDA policy shifts and the rise of blockbuster obesity drugs, a new Evaluate report confirms rare disease therapies are on track to claim more than a fifth of all global...

Orphan drug sales to exceed $400bn by 2032, Evaluate report finds

Read more
Manufacturing Sale of CHI business to Lone Star funds marks final step in Lonza’s strategic shift to a focused CDMO model

Lonza completes transformation to pure-play CDMO with agreement to divest Capsules & Health Ingredients

Read more
Research & Development The parternship will allow kyron.bio to apply its precision glycoengineering platform to antibody development. Speaking exclusively with Manufacturing Chemist, CEO of...

kyron.bio partners with Servier to advance precision glycosylation in antibody therapeutics

Read more